<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27607" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Peripheral Precocious Puberty</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Qudsiya</surname>
            <given-names>Zainab</given-names>
          </name>
          <aff>Gulf Medical University, Ajman</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zainab Qudsiya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27607.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Precocious puberty is traditionally defined as the appearance of secondary sexual characteristics before the age of&#x000a0;8 years in girls and&#x000a0;9 years in boys. Peripheral precocious puberty, also known as precocious pseudopuberty, is gonadotropin-independent and occurs due to excess production of sex hormones from the gonads, the adrenal glands, or exogenous sources. This activity reviews the evaluation and management of peripheral precocious puberty and highlights the role of the healthcare team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Apply&#x000a0;the pathophysiology of peripheral precocious puberty to evaluation.&#x000a0;</p></list-item><list-item><p>Implement appropriate&#x000a0;evaluation strategies in patients with peripheral precocious puberty.</p></list-item><list-item><p>Apply best practices when managing peripheral precocious puberty.</p></list-item><list-item><p>Collaborate with the interprofessional team to plan effective communication options to patients and their families.&#x000a0;</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27607&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27607">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27607.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Precocious puberty is defined as the appearance of secondary sexual characteristics before the age of 8 years in girls and 9 years in boys.<xref ref-type="bibr" rid="article-27607.r1">[1]</xref> Precocious puberty is classified as either central or peripheral precocious puberty. Central precocious puberty is gonadotropin-dependent and occurs due to early activation of the hypothalamic-pituitary-gonadal axis. Peripheral precocious puberty, also known as peripheral precocious puberty, is gonadotropin-independent and occurs due to excess production of sex hormones either from the gonads, the adrenal glands, ectopic or exogenous sources.</p>
        <p>Precocious puberty is isosexual if the signs of sexual development are consistent with the phenotypic gender of the child before the earliest accepted age of sexual maturation. If the signs of sexual development are inappropriate for the patient&#x02019;s gender, then it is considered contrasexual. If left untreated, peripheral precocious puberty can lead to short stature in adulthood and have psychological consequences on the individual. Therefore, early recognition and treatment&#x000a0;of this condition are essential to reduce morbidity.</p>
      </sec>
      <sec id="article-27607.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>
<bold>Girls</bold>
</p>
        <p>
<bold>Ovarian cysts</bold>
</p>
        <p>Functioning follicular cysts are the most common cause of peripheral precocious puberty in girls. Functional follicular cysts secrete estrogen and can present as premature breast development. Vaginal bleeding may also occur after cysts degenerate.<xref ref-type="bibr" rid="article-27607.r2">[2]</xref></p>
        <p>
<bold>Ovarian tumors</bold>
</p>
        <p>Ovarian tumors such as granulosa cell tumors, Sertoli/Leydig cell tumors, Leydig cell tumors, and gonadoblastoma can all result in precocious puberty. Granulosa cell tumor is the most common&#x000a0;sex cord tumor in girls and is associated with excess estrogen production, which can lead to isosexual precocious puberty. On the other hand, gonadoblastoma, Leydig cell tumors, and Sertoli/Leydig tumors lead to excess androgen production and can present with contrasexual precocious puberty.<xref ref-type="bibr" rid="article-27607.r3">[3]</xref><xref ref-type="bibr" rid="article-27607.r2">[2]</xref></p>
        <p>
<bold>Boys</bold>
</p>
        <p>
<bold>Leydig cell tumors</bold>
</p>
        <p>Leydig cell tumor is the most common testicular sex cord-stromal tumor and is associated with excess testosterone production. This condition commonly presents with asymmetric testicular enlargement and precocious puberty between the ages of 6 and 10 years in boys.<xref ref-type="bibr" rid="article-27607.r4">[4]</xref></p>
        <p>
<bold>Human chorionic gonadotropin-secreting tumors</bold>
</p>
        <p>Excess human&#x000a0;chorionic&#x000a0;gonadotropin-secreting&#x000a0;tumors (hCG) production from testicular tumors (embryonal cell carcinoma, choriocarcinoma) and ectopic sites (pineal gland, mediastinum, liver, retroperitoneum) can lead to isosexual precocious puberty in boys.<xref ref-type="bibr" rid="article-27607.r5">[5]</xref></p>
        <p>
<bold>Familial male-limited precocious puberty</bold>
</p>
        <p>Familial male-limited precocious puberty is a rare condition that can cause isosexual peripheral precocious puberty in boys. It presents in boys as young as&#x000a0;2 years with precocious puberty, symmetric testicular enlargement, and a positive family history of precocious puberty in male relatives.</p>
        <p>
<bold>Boys and Girls</bold>
</p>
        <p>
<bold>Primary hypothyroidism</bold>
</p>
        <p>Long-standing untreated primary hypothyroidism can present as precocious puberty in boys and girls.&#x000a0;Girls affected by this condition present with early breast development and galactorrhea, followed by vaginal bleeding. Van Wyk and Grumbach syndrome refers to the combination of primary hypothyroidism, precocious puberty, delayed bone age, and ovarian cysts in girls. In boys, primary hypothyroidism may cause premature testicular enlargement.<xref ref-type="bibr" rid="article-27607.r6">[6]</xref><xref ref-type="bibr" rid="article-27607.r7">[7]</xref></p>
        <p>
<bold>McCune-Albright syndrome</bold>
</p>
        <p>McCune Albright Syndrome is a rare condition that can present with irregular caf&#x000e9; au lait spots, polyostotic fibrous dysplasia, and peripheral precocious puberty in girls. Estrogen overproduction in this condition leads to early breast development, vaginal bleeding, recurrent follicular cysts, and accelerated bone growth. At times, vaginal bleeding may precede the onset of breast development. McCune-Albright syndrome can also present with endocrinopathies such as thyrotoxicosis, Cushing syndrome, gigantism, or acromegaly.<xref ref-type="bibr" rid="article-27607.r8">[8]</xref></p>
        <p>
<bold>Adrenal pathology</bold>
</p>
        <p>Excess adrenal production of androgens can occur secondary to congenital adrenal hyperplasia or adrenal tumors and present with isosexual precocious puberty in males and contrasexual precocious puberty in females. Excess androgen production in congenital adrenal hyperplasia can occur due to a deficiency in either 21-hydroxylase or 11-beta-hydroxylase deficiency. At times, adrenal tumors may secrete estrogen only or both estrogen and androgens.<xref ref-type="bibr" rid="article-27607.r8">[8]</xref></p>
        <p>
<bold>Exogenous sex steroids/endocrine-disrupting chemicals</bold>
</p>
        <p>Inadvertent exposure to androgen, estrogen, or endocrine-disrupting chemicals from exogenous sources can lead to precocious puberty in both genders and gynecomastia in males.<xref ref-type="bibr" rid="article-27607.r9">[9]</xref>&#x000a0;Accidental exposure to estrogens may occur in the form of creams, ointments, or oral contraceptive pills prescribed for adults. Estrogen is also present in food sources such as soy products and some folk remedies. Exposure to androgen-containing topical creams can lead to virilization and precocious puberty in girls.<xref ref-type="bibr" rid="article-27607.r10">[10]</xref>&#x000a0;Endocrine-disrupting chemicals that interfere with the natural synthesis and function of hormones are found in pesticides, plasticizers, lavender, fennel, and tea tree oils and can lead to precocious puberty.<xref ref-type="bibr" rid="article-27607.r11">[11]</xref></p>
      </sec>
      <sec id="article-27607.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of precocious puberty is estimated to be between 1:5000 to 1:10,000.<xref ref-type="bibr" rid="article-27607.r12">[12]</xref>&#x000a0;Peripheral precocious puberty is less common than central precocious puberty. An Iranian case series estimated that 23.3% of cases of precocious puberty are due to peripheral causes.<xref ref-type="bibr" rid="article-27607.r13">[13]</xref>&#x000a0;The prevalence of peripheral precocious puberty varies depending on the underlying cause. For example, non-classic congenital adrenal hyperplasia affects 0.1% of the worldwide population and is more common in Hispanics, Mediterranean, Eastern European Jews, and Yugoslavs.<xref ref-type="bibr" rid="article-27607.r14">[14]</xref>&#x000a0;McCune Albright syndrome is a rare condition with a prevalence of 1/100,000 to 1/1,000,000 and is more common in females.<xref ref-type="bibr" rid="article-27607.r15">[15]</xref>&#x000a0;Familial male precocious puberty is also rare, with a prevalence of &#x0003c;1/1,000,000.<xref ref-type="bibr" rid="article-27607.r16">[16]</xref></p>
        <p>Overall, precocious puberty is&#x000a0;10 times more common in females than in males.<xref ref-type="bibr" rid="article-27607.r17">[17]</xref>&#x000a0;Specific causes of peripheral precocious puberty may show a sex preference. For example, McCune Albright syndrome is more common in females, while familial male precocious puberty only affects males.</p>
        <p>Although the traditional age cut-off for precocious puberty is&#x000a0;8 years for girls and 9 years for boys, data from European studies indicate an overall decline in the age of onset of puberty in the past few decades.<xref ref-type="bibr" rid="article-27607.r18">[18]</xref>&#x000a0;A trend towards an earlier onset of puberty has been attributed to genetic factors, obesity, and exposure to endocrine-disrupting chemicals. For example, menarche has been observed to occur earlier in girls with high body mass index, low birth weight, and whose mothers had early menarche. A significant racial variation in the age of onset of pubertal changes has also been observed in multiple studies. For example, cross-sectional studies conducted in the US indicate that African American girls tend to experience puberty earliest, followed by Hispanic and then Caucasian girls.</p>
        <p>A multicenter study involving subjects in San Fransisco, New York, and Cincinnati also confirmed this finding. They also found that breast development is present in 23% of African Americans, 15% of Hispanics, and 10% of&#x000a0;White girls between the ages of 7 to 8 years.<xref ref-type="bibr" rid="article-27607.r19">[19]</xref>&#x000a0;Similarly, testicular enlargement occurs approximately one year earlier in African American boys (mean age 9.14 years) compared to White race (10.14 years) and Hispanic (10.04) boys.<xref ref-type="bibr" rid="article-27607.r1">[1]</xref>&#x000a0;Due to observed racial differences in the mean age of puberty, the Lawson Wilkins Pediatric Endocrine Society (LWEPS) recommends evaluation if breast development or pubic hair appears before the age of&#x000a0;7 in Caucasian girls and&#x000a0;6 years in African American girls.</p>
      </sec>
      <sec id="article-27607.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Normal Puberty</bold>
</p>
        <p>Puberty is the transition of a child to sexual maturity and is marked by activation of the hypothalamic-pituitary-gonadal axis. A surge in the secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus stimulates the pituitary to increase its secretion of follicular stimulating hormone (FSH) and luteinizing hormone (LH). An increase in the basal levels of FSH and LH leads to activation of gonads, and an event referred to as "<italic toggle="yes">gonadarche,"</italic> which is the main event in puberty. Activation of the gonads leads to an increase in the secretion of sex hormones, estrogen in girls, and testosterone in boys. In girls, an increase in estradiol leads to breast development (<italic toggle="yes">thelarche</italic>), an increase in bone mineral density, linear skeletal growth (<italic toggle="yes">growth spurt)</italic>, and eventually epiphyseal fusion, which leads to the cessation of linear growth. The peripubertal rise of FSH also causes an increase in uterine volume and growth of ovarian follicles, which leads to cyclical ovulation and menstruation (<italic toggle="yes">menarche</italic>). "<italic toggle="yes">Adrenarche</italic>" occurs due to a pubertal increase in the secretion of adrenal androgens-dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS). Adrenarche manifests as an increase in pubic and axillary hair growth ("pubarche"), acne, and adult-type body odor. Other pubertal changes include an increase in the secretion of growth hormone and weight and body composition changes.<xref ref-type="bibr" rid="article-27607.r20">[20]</xref></p>
        <p>In girls, breast budding (Thelarche) is the first detectable secondary sexual characteristic. However, pubarche is the initial manifestation in 15% of girls.<xref ref-type="bibr" rid="article-27607.r21">[21]</xref>&#x000a0;On average, menarche occurs 2 years after thelarche.<xref ref-type="bibr" rid="article-27607.r22">[22]</xref>&#x000a0;A peak in height velocity leads to a growth spurt, which occurs before menarche at approximately 12 years of age in girls. In boys, the first detectable sign of puberty is testicular enlargement, defined as a testicular diameter greater than 2.5 cm or testicular volume greater than 4 mL. Penile growth and pubarche occur approximately 6 months after testicular enlargement. Growth spurt in boys occurs later compared to girls at an average age of 14 years.</p>
        <p>
<bold>Peripheral Precocious Puberty</bold>
</p>
        <p>In peripheral precocious puberty, the excess secretion of sex hormones occurs from the gonads, adrenal glands, or ectopic or exogenous sources. This process does not depend on the activation of the hypothalamic-pituitary-gonadal axis and is associated with suppressed levels of GnRH, FSH, and LH. The exact pathophysiology varies depending on the underlying disorders:</p>
        <list list-type="bullet">
          <list-item>
            <p>HCG-producing tumors: excess testosterone production occurs due to stimulation of the LH receptors on the Leydig cells, which leads to testicular enlargement and isosexual precocious puberty in boys.</p>
          </list-item>
          <list-item>
            <p>Congenital adrenal hyperplasia: excess androgen production occurs most commonly due to 21 hydroxylase deficiency or less commonly due to 11&#x003b2;-hydroxylase deficiency. Both these disorders lead to a decrease in cortisol production, which stimulates adrenocorticotropic hormone (ACTH) secretion and accumulation of cortisol precursors. The cortisol precursors are then redirected to the androgen pathway leading to excess androgen production. This manifests as virilization in girls (hirsutism, clitoromegaly), isosexual precocious puberty in boys, and signs of adrenarche (axillary, pubic hair, body odor, and acne) in both sexes.<xref ref-type="bibr" rid="article-27607.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>Primary hypothyroidism: peripheral precocious puberty occurs due to stimulation of the FSH receptors as thyroid-stimulating hormone (TSH) and follicular stimulating hormone (FSH) are structurally similar. Stimulation of the ovaries causes estrogen production, which leads to premature breast development and galactorrhea, followed by vaginal bleeding. It also leads to the development of ovarian cysts. "Van Wyk and Grumbach syndrome" refers to the combination of primary hypothyroidism, precocious puberty, delayed bone age, and ovarian cysts in girls. In boys, this condition presents with premature testicular enlargement.</p>
          </list-item>
          <list-item>
            <p>McCune Albright syndrome: This condition occurs due to a post-zygotic activating mutation of the GNAS gene coding for the alpha subunit of the Gs protein, which leads to overactivity of the cyclic adenosine monophosphate (cAMP) pathway. Stimulation of the cAMP pathway leads to the formation of functional follicular ovarian cysts, which lead to signs of estrogen excess and precocious puberty in girls.<xref ref-type="bibr" rid="article-27607.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Familial male-limited precocious puberty: FMPP is an autosomal dominant condition caused by an activating mutation of the luteinizing hormone (LH) receptor. This causes premature stimulation of the Leydig cells in the absence of Luteinizing hormone-releasing hormone (LHRH) and increased testosterone production in boys.<xref ref-type="bibr" rid="article-27607.r24">[24]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27607.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histopathology differs depending on the underlying cause:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ovarian cysts: Follicular cysts appear histologically as thin-walled cysts containing follicular fluid and are lined by granulosa and theca interna cells.<xref ref-type="bibr" rid="article-27607.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p>Ovarian tumors:&#x000a0; the appearance of granulosa cell tumors varies depending on the type of cells (adult vs juvenile). Adult-type granulosa cells appear as elongated pale cells with scant cytoplasm and grooved nuclei. These cells often appear as rosettes around collections of eosinophilic fluid referred to as "Call-Exner bodies" and resemble primordial follicles. Juvenile-type granulosa cells appear as immature cells with frequent mitotic activity.<xref ref-type="bibr" rid="article-27607.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p>Leydig cell tumors: Leydig cell tumors histologically appear as groups of large cells with regular round nuclei and eosinophilic cytoplasm. Eosinophilic cytoplasmic inclusions referred to as Reinke crystals, characteristic of Leydig cell tumors, may also be seen.</p>
          </list-item>
          <list-item>
            <p>Congenital adrenal hyperplasia: histological features include diffuse cortical hyperplasia.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27607.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>History</bold>
</p>
        <p>The first step of approaching precocious puberty is to elicit a detailed history and conduct a comprehensive physical exam. History taking should begin by inquiring about the age of onset of signs of sexual development. Generally, the threshold for evaluating pubertal signs is 8 years in girls and&#x000a0;9 years in boys.</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients should be asked explicitly about the type of pubertal changes and progression rate as it can help guide evaluation. Signs of androgen excess such as pubic and axillary hair growth, acne, adult-type body odor,&#x000a0; and hirsutism indicate adrenal pathology. On the other hand, breast development and menstrual bleeding indicate estrogen excess.</p>
          </list-item>
          <list-item>
            <p>Rapid progression of pubertal signs may indicate an underlying testicular, ovarian, or adrenal tumor. Establishing the sequence of pubertal changes is essential as peripheral precocious puberty often presents with an abnormal sequence. For example, in McCune-Albright syndrome, menstrual bleeding may precede the onset of breast development.<xref ref-type="bibr" rid="article-27607.r27">[27]</xref></p>
          </list-item>
          <list-item>
            <p>Patients should also be inquired about a recent increase in height.&#x000a0; Usually, patients with peripheral precocious puberty have a rapid increase in height velocity, causing them to move up to higher centiles on the growth chart, at least initially.</p>
          </list-item>
          <list-item>
            <p>A history of neurological symptoms (headache, visual changes, seizures) should be elicited to exclude a central cause for precocious puberty. A history of chronic disease and insults to the central nervous system (head trauma, perinatal asphyxia, neoplasms, radiation) should also be noted.</p>
          </list-item>
          <list-item>
            <p>Patients should be inquired about the ingestion of sex hormones or exposure to topical agents with estrogenic/androgenic/endocrine-disrupting activity.</p>
          </list-item>
          <list-item>
            <p>Family history should focus on the timing of pubertal onset in parents, history of ambiguous genitalia in siblings (possible congenital adrenal hyperplasia), and history of precocity in male relatives (familial male limited precocious puberty).</p>
          </list-item>
        </list>
        <p>
<bold>Physical Exam</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The initial step in the physical exam is to record the vital signs. The presence of hypertension may indicate congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency and bradycardia may indicate hypothyroidism.</p>
          </list-item>
          <list-item>
            <p>Growth parameters, including height, weight, and head circumference, should be plotted to determine the growth velocity.</p>
          </list-item>
          <list-item>
            <p>The general exam should focus on looking for signs of specific conditions such as thyroid enlargement and caf&#x000e9; au lait spots. In McCune Albright syndrome, the caf&#x000e9;-au-lait spots have a "<italic toggle="yes">Coast of Maine</italic>" appearance and are described as large, hyperpigmented spots with irregular borders and a segmental distribution. These should be differentiated from the caf&#x000e9; au lait spots of neurofibromatosis, which tend to have regular borders. Other findings seen in McCune Albright syndrome include polyostotic fibrous dysplasia, which presents as bony deformities, pathological fractures, gait abnormalities, and bone pain.</p>
          </list-item>
          <list-item>
            <p>Neurological exam and visual field testing should be done to detect neurological deficits secondary to a possible intracranial mass. An abdominal exam should be done to identify any palpable masses that could arise due to adrenal or ovarian tumors.</p>
          </list-item>
          <list-item>
            <p>The most important part of the exam is to grade sexual maturity using the Tanner staging. Sexual maturity rating (SMR) is determined for pubic hair, breast and genitalia development, and graded on a scale of 1 to 5, with 1 representing prepuberty and 5 representing adult development. While assessing breast development in girls, care should be taken to distinguish between irregular ductal breast tissue the subcutaneous tissue, which is smooth and soft. Similarly, palpation of the testes, measurement of stretched penile length, and testicular volume with an orchidometer should be done accurately. Penile dimensions disproportionately greater than testicular dimensions indicate peripheral precocious puberty due to adrenal pathology. Moderate symmetric enlargement of testes may indicate familial male limited precocious puberty or an HCG-secreting tumor. On the other hand, asymmetric testicular enlargement and a palpable testicular mass may indicate a Leydig cell tumor.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27607.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Lab Investigations</bold>
</p>
        <p>
<bold>Sex hormones</bold>
</p>
        <p>Baseline measurement of testosterone in boys and estradiol&#x000a0;in girls should be obtained. The elevation of baseline sex hormones with suppressed gonadotropins indicates peripheral precocious puberty. A significantly elevated testosterone level indicates testicular neoplasm in boys or an adrenal source in both boys and girls. In girls, estradiol levels are interpreted with reference to the tanner stage of breast development. Estradiol levels of greater than 20 pg/mL indicate puberty. Significantly elevated serum estradiol levels (&#x0003e;100 pg/mL) in a girl indicate either an estrogen-secreting ovarian cyst or ovarian tumor. On the other hand, a low baseline estradiol level of less than 10 pg/mL indicates central precocious puberty.</p>
        <p>
<bold>Luteinizing hormone, follicular stimulating hormone, and human chorionic gonadotropin levels</bold>
</p>
        <p>In peripheral precocious puberty, the baseline luteinizing hormone (LH) and&#x000a0;follicular stimulating hormone&#x000a0;(FSH) levels are in the prepubertal range. Basal LH levels should be measured early in the morning. Basal LH levels less than 0.2 mIU/mL indicate peripheral precocious puberty or benign pubertal variants. Random measurements of FSH are not very useful in diagnosis. Elevated HCG levels indicate the presence of HCG-secreting tumors such as embryonal cell carcinoma, choriocarcinoma, and dysgerminoma.&#x000a0;</p>
        <p>
<bold>Serum adrenal steroids</bold>
</p>
        <p>Measuring serum adrenal steroid levels is useful in differentiating premature adrenarche from peripheral precocious puberty. In patients with premature adrenarche, levels of dehydroepiandrosterone sulfate (40-135 mcg/dL), testosterone (1.1-3.7 micromol/L), and 17 hydroxyprogesterone (115-200 ng/dL) are only mildly elevated. Elevation of DHEAS and testosterone above these ranges indicates adrenal tumors or congenital adrenal hyperplasia. An elevated early morning 17 hydroxyprogesterone (&#x0003e;200 ng/dL) indicates non-classical congenital hyperplasia due to 21 hydroxylase deficiency. Elevated 11 deoxy cortisol and deoxy cortisone indicate 11 B hydroxylase deficiency.<xref ref-type="bibr" rid="article-27607.r28">[28]</xref><xref ref-type="bibr" rid="article-27607.r29">[29]</xref><xref ref-type="bibr" rid="article-27607.r30">[30]</xref></p>
        <p>
<bold>Thyroid function test</bold>
</p>
        <p>Serum thyroid-stimulating hormone (TSH) concentration and free T4 levels should be checked in patients with signs and symptoms of primary hypothyroidism.</p>
        <p>
<bold>Radiology</bold>
</p>
        <p>
<bold>Bone age assessment</bold>
</p>
        <p>Radiographs of the hand and wrist should be&#x000a0;performed in cases of suspected precocious puberty to assess epiphyseal maturation. An average or slightly delayed bone age&#x000a0; (&#x0003c;2 years of&#x000a0;chronological age) suggests benign variants such as premature thelarche or premature adrenarche. On the other hand, significantly advanced bone age (&#x0003e;2 standard deviations above the mean for age) indicates accelerated linear growth and precocious puberty. Rapidly progressive bone age should raise concern for congenital adrenal hyperplasia or tumors originating from the ovaries, adrenal glands, or germ cells.<xref ref-type="bibr" rid="article-27607.r31">[31]</xref></p>
        <p>
<bold>Ultrasound/computer tomography</bold>
</p>
        <p>In girls with suspected peripheral precocious puberty, a pelvic ultrasound is essential to determine&#x000a0;if ovarian cysts or tumors are the underlying etiology. Pelvic ultrasound is also helpful in determining the uterine length and volume,&#x000a0;which&#x000a0;is a good indicator of the duration of estrogen exposure.<xref ref-type="bibr" rid="article-27607.r32">[32]</xref><xref ref-type="bibr" rid="article-27607.r33">[33]</xref>&#x000a0;In boys, testicular ultrasound is helpful in identifying malignancies, such as Leydig cell tumors. In patients with clinical signs or lab evidence of excess adrenal androgens, an abdominal ultrasound or computer tomography of the abdomen is recommended.</p>
        <p>
<bold>&#x000a0;Other Tests</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients with urological symptoms or visual changes require brain magnetic resonance imaging to exclude intracranial pathology. Brain imaging is also indicated to identify HCG, producing pineal gland tumors.</p>
          </list-item>
          <list-item>
            <p>Bone scans and&#x000a0;skeletal surveys are&#x000a0;required in cases of suspected McCune-Albright syndrome to identify fibrous dysplasia.</p>
          </list-item>
          <list-item>
            <p>Genetic testing&#x000a0;may be required&#x000a0;to identify mutations and confirm the diagnosis in patients with congenital adrenal hyperplasia, familial male-limited precocious puberty, and McCune-Albright syndrome.<xref ref-type="bibr" rid="article-27607.r34">[34]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27607.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Cases of peripheral precocious puberty should be promptly referred to an endocrinologist to prevent complications. The goals of managing peripheral precocious puberty are to treat the underlying cause and block the production or response of excess sex hormones. Specific treatments depend on the cause:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Tumors</bold> of the ovary, testis, or adrenal glands often require surgical excision. HCG-secreting tumors may require additional treatment with chemotherapy or radiotherapy.</p>
          </list-item>
          <list-item>
            <p><bold>Functional follicular ovarian cysts</bold> rarely require surgical intervention and may be managed conservatively as they usually regress spontaneously.<xref ref-type="bibr" rid="article-27607.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Primary hypothyroidism</bold> is treated by providing thyroxine supplementation.</p>
          </list-item>
          <list-item>
            <p><bold>McCune-Albright syndrome:</bold> Aromatase inhibitors are the most studied medications to manage precocious puberty in McCune-Albright syndrome. Theoretically, aromatase inhibitors suppress estrogen production and help in slowing growth maturation, leading to the cessation of menses and reducing ovarian volumes. However, studies have shown mixed results. Testolactone has been shown to be temporarily effective in slowing the growth rate and advancement of menses, while fadrozole and anastrozole have not been found to be efficacious.<xref ref-type="bibr" rid="article-27607.r36">[36]</xref><xref ref-type="bibr" rid="article-27607.r37">[37]</xref>&#x000a0;On the other hand, letrozole, a 3rd generation aromatase inhibitor, was found to decrease growth rate and advancement in bone age significantly.&#x000a0; Long term safety of letrozole is yet to be established.<xref ref-type="bibr" rid="article-27607.r38">[38]</xref>&#x000a0;Tamoxifen, a selective estrogen receptor modulator, is effective in halting pubertal progression but is associated with long-term safety concerns due to endometrial stimulation.<xref ref-type="bibr" rid="article-27607.r39">[39]</xref>&#x000a0;Many patients with McCune Albright syndrome with advanced bone age develop central precocious puberty. In such patients, treatment with gonadotropin agonists may be helpful.</p>
          </list-item>
          <list-item>
            <p><bold>Familial male-limited precocious puberty:</bold> This disorder is treated with an androgen receptor antagonist and aromatase inhibitor to delay epiphyseal maturation. A GnRH analog is added in cases where central precocious puberty occurs.&#x000a0; A case series of 25 subjects with familial male-limited precocious puberty showed that spironolactone with testolactone or anastrozole and a GnRH agonist was effective in increasing adult height.<xref ref-type="bibr" rid="article-27607.r40">[40]</xref>&#x000a0;Other drugs used to manage this condition include ketoconazole, which is a steroid synthesis inhibitor, and bicalutamide, which is an anti-androgen and letrozole.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27607.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Benign or Non-Progressive Pubertal Variants</bold>
</p>
        <p>Benign pubertal variants represent cases of early secondary sexual development that are not progressive, have normal height velocity, and are not associated with an underlying pathological process. Most of these variants require no treatment apart from reassurance and close monitoring for signs of pubertal progression, bone age, and acceleration in height velocity.</p>
        <p>Variants under this category include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Premature thelarche </bold>is isolated breast development in young girls without the development of other secondary sexual characteristics. This condition is usually seen in girls younger than&#x000a0;6 to&#x000a0;8 years. Breast development in premature thelarche often does not progress beyond tanner stage 3. The presence of normal height velocity, normal bone age, and absence of other secondary sexual characteristics differentiate this condition from peripheral precocious puberty.</p>
          </list-item>
          <list-item>
            <p><bold>Premature pubarche</bold> is the isolated development of pubic and axillary hair before the age of&#x000a0;8 years in girls and&#x000a0;9 years in boys. This condition may be associated with a mild elevation in dehydroepiandrosterone sulfate and mild advancement in bone age. Patients with premature pubarche require close monitoring as it may be the initial sign of peripheral precocious puberty. Signs of virilization, growth acceleration, and significant advancement in bone age in these patients should prompt a workup for congenital adrenal hyperplasia or virilizing adrenal tumors.</p>
          </list-item>
          <list-item>
            <p><bold>Benign prepubertal vaginal bleeding</bold> is the presence of isolated prepubertal vaginal bleeding that resolves spontaneously. The diagnosis of this condition requires the exclusion of other causes of vaginal bleeding, such as sexual abuse, foreign body, or local trauma. The absence of other secondary sexual characteristics, a normal pelvic ultrasound, and prepubertal gonadotropin levels differentiate this condition from precocious puberty.</p>
          </list-item>
        </list>
        <p>
<bold>Central Precocious Puberty</bold>
</p>
        <p>Central precocious puberty occurs due to premature activation of the hypothalamic-pituitary-gonadal axis and can be idiopathic, genetic, or due to central nervous system lesions. Unlike peripheral precocious puberty, patients with central precocious puberty tend to follow the normal sequence of secondary sexual development. They may also have neurological signs or visual changes. Central precocious puberty is gonadotropin-independent and is associated with elevated levels of the follicular stimulating hormone (FSH) and luteinizing hormone (LH). Central precocious puberty can be confirmed by a basal LH concentration of greater than 0.3 IU/L or an elevation of LH in response to GnRH stimulation test.<xref ref-type="bibr" rid="article-27607.r41">[41]</xref><xref ref-type="bibr" rid="article-27607.r42">[42]</xref></p>
      </sec>
      <sec id="article-27607.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis of McCune Albright syndrome varies depending on the severity of bone disease and the number of endocrinopathies. The outcome of non-classical congenital adrenal hyperplasia is generally favorable if glucocorticoids are administered early. However, despite treatment, many patients go on to develop short stature in adulthood. The prognosis of ovarian granulosa cell tumors depends on the stage of the disease and the presence of residual disease.<xref ref-type="bibr" rid="article-27607.r43">[43]</xref>&#x000a0;Similarly, Leydig tumors have an excellent prognosis and high disease-free survival rates if the condition is localized. However, metastatic disease is associated with poor outcome.<xref ref-type="bibr" rid="article-27607.r44">[44]</xref>&#x000a0;Cases of peripheral precocious puberty caused by exogenous hormones or endocrine-disrupting chemicals resolve spontaneously upon discontinuing exposure.</p>
      </sec>
      <sec id="article-27607.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Patients with precocious puberty may encounter different complications, depending on the primary diagnosis:</p>
        <list list-type="bullet">
          <list-item>
            <p>Short stature patients with precocious puberty initially have a growth spurt in adolescence due to rapid linear growth. However, if left untreated, this is followed by premature fusion of the epiphyseal plates, which leads to short stature in adulthood.</p>
          </list-item>
          <list-item>
            <p>Early development of breasts in girls and increased libido in boys can cause significant emotional distress.</p>
          </list-item>
          <list-item>
            <p>The changes associated with puberty may lead to long term psychosocial stress, behavioral issues, and psychiatric problems such as depression.</p>
          </list-item>
          <list-item>
            <p>Contrasexual precocious puberty in girls caused by excess androgens can lead to virilization in the form of clitoromegaly, which may require genital reconstructive surgery.</p>
          </list-item>
          <list-item>
            <p>Patients with McCune Albright syndrome can develop musculoskeletal complications (bone pain, deformities, pathological fractures, gait abnormalities) and endocrinopathies (acromegaly, hyperthyroidism, Cushing syndrome). They are also at risk of developing arrhythmias, intestinal polyps, and malignancies.</p>
          </list-item>
          <list-item>
            <p>Patients with congenital adrenal hyperplasia may suffer from suboptimal fertility. They can also develop complications due to chronic glucocorticoid therapy, e.g., cushingoid features, poor growth, osteoporosis, secondary diabetes, and adrenal suppression. Women with congenital adrenal hyperplasia have a higher risk of requiring cesarian delivery due to underlying cephalopelvic disproportion.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27607.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with peripheral precocious puberty should be offered psychological and emotional support as the physical changes of puberty may lead to emotional distress. Affected patients are often subjected to higher societal expectations based on their physical maturity rather than their age. Parents and teachers, therefore, need to be counseled and reminded to maintain age-appropriate expectations. Patients who experience early puberty may start engaging in risk-taking behavior (drugs, alcohol use, ad sexual activity) at an earlier age and require age-appropriate sex education.</p>
      </sec>
      <sec id="article-27607.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with peripheral precocious puberty are usually seen initially by a primary care physician or pediatrician. All physicians should be aware of the physiological pubertal changes, their normal sequence, and the age cutoff for considering pubertal changes as precocious. The onset&#x000a0;of puberty before the age of&#x000a0;6 years in African American girls,&#x000a0;7 years in caucasian girls, and&#x000a0;9 years in boys should be evaluated thoroughly for precocious puberty.<xref ref-type="bibr" rid="article-27607.r45">[45]</xref>&#x000a0;Cases of peripheral precocious puberty should be promptly identified and referred to a pediatric endocrinologist for further management to prevent the development of short stature in adulthood.</p>
        <p>Although primarily managed by an endocrinologist, patients often require&#x000a0;interprofessional care. Consultations with oncology are required in cases of precocious puberty due to malignancy. Referral to surgery may be required for surgical excision of an underlying adrenal, ovarian, or testicular tumor. A referral to urology may be required due to the proximity of the gonads to the genitourinary system. Patients with McCune Albright syndrome may require referral to orthopedics to correct bone deformities due to fibrous dysplasia. Patients with peripheral precocious puberty can develop depression or behavioral disorders, which may require consultation with a psychiatrist and a child psychologist. Interdisciplinary collaboration is essential for optimal patient outcomes for those with&#x000a0;peripheral precocious puberty.</p>
      </sec>
      <sec id="article-27607.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27607&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27607">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/peripheral-precocious-puberty/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27607">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27607/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27607">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27607.s16">
        <title>References</title>
        <ref id="article-27607.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carel</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>L&#x000e9;ger</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice. Precocious puberty.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>May</month>
            <day>29</day>
            <volume>358</volume>
            <issue>22</issue>
            <fpage>2366</fpage>
            <page-range>2366-77</page-range>
            <pub-id pub-id-type="pmid">18509122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhivyalakshmi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bhattacharyya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Arulselvi</surname>
                <given-names>KI</given-names>
              </name>
            </person-group>
            <article-title>Precocious pseudopuberty due to ovarian causes.</article-title>
            <source>Indian Pediatr</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>51</volume>
            <issue>10</issue>
            <fpage>831</fpage>
            <page-range>831-3</page-range>
            <pub-id pub-id-type="pmid">25362018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marx</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Hyperplasia in glands with hormone excess.</article-title>
            <source>Endocr Relat Cancer</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>R1</fpage>
            <page-range>R1-14</page-range>
            <pub-id pub-id-type="pmid">26407873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a Gonz&#x000e1;lez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Casal-Beloy</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Somoza Argibay</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dargallo Carbonell</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Atypical presentation of Leydig cell tumour in three prepubertal patients: diagnosis, treatment and outcomes.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2019</year>
            <month>Apr</month>
            <day>24</day>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>369</fpage>
            <page-range>369-374</page-range>
            <pub-id pub-id-type="pmid">30875329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gattuso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Casanova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Biassoni</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Terenziani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schiavello</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sironi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Collini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pallotti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Morosi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Massimino</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Precocious pseudopuberty, a paraneoplastic manifestation: a report of 2 cases.</article-title>
            <source>Tumori</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>106</volume>
            <issue>6</issue>
            <fpage>NP14</fpage>
            <page-range>NP14-NP17</page-range>
            <pub-id pub-id-type="pmid">32462993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baranowski</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>H&#x000f6;gler</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>An unusual presentation of acquired hypothyroidism: the Van Wyk-Grumbach syndrome.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>166</volume>
            <issue>3</issue>
            <fpage>537</fpage>
            <page-range>537-42</page-range>
            <pub-id pub-id-type="pmid">22170796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cabrera</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>DiMeglio</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Eugster</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Incidence and characteristics of pseudoprecocious puberty because of severe primary hypothyroidism.</article-title>
            <source>J Pediatr</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>162</volume>
            <issue>3</issue>
            <fpage>637</fpage>
            <page-range>637-9</page-range>
            <pub-id pub-id-type="pmid">23196132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haddad</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Eugster</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>101273</fpage>
            <pub-id pub-id-type="pmid">31027974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henley</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Lipson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Korach</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Bloch</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Prepubertal gynecomastia linked to lavender and tea tree oils.</article-title>
            <source>N Engl J Med</source>
            <year>2007</year>
            <month>Feb</month>
            <day>01</day>
            <volume>356</volume>
            <issue>5</issue>
            <fpage>479</fpage>
            <page-range>479-85</page-range>
            <pub-id pub-id-type="pmid">17267908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinez-Pajares</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Diaz-Morales</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ramos-Diaz</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Gomez-Fernandez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Peripheral precocious puberty due to inadvertent exposure to testosterone: case report and review of the literature.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2012</year>
            <volume>25</volume>
            <issue>9-10</issue>
            <fpage>1007</fpage>
            <page-range>1007-12</page-range>
            <pub-id pub-id-type="pmid">23426834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Breil</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yakovenko</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Inta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Choukair</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Klose</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mittnacht</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schulze</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alrajab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grulich-Henn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bettendorf</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Typical characteristics of children with congenital adrenal hyperplasia due to 11&#x003b2;-hydroxylase deficiency: a single-centre experience and review of the literature.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2019</year>
            <month>Mar</month>
            <day>26</day>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>259</fpage>
            <page-range>259-267</page-range>
            <pub-id pub-id-type="pmid">30817301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Partsch</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Sippell</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens.</article-title>
            <source>Hum Reprod Update</source>
            <year>2001</year>
            <season>May-Jun</season>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>292</fpage>
            <page-range>292-302</page-range>
            <pub-id pub-id-type="pmid">11392376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rohani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Salehpur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saffari</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Etiology of precocious puberty, 10 years study in Endocrine Reserch Centre (Firouzgar), Tehran.</article-title>
            <source>Iran J Reprod Med</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">25242967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Binay</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Simsek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cilingir</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Yuksel</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kutlay</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Artan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of nonclassic congenital adrenal hyperplasia in Turkish children presenting with premature pubarche, hirsutism, or oligomenorrhoea.</article-title>
            <source>Int J Endocrinol</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>768506</fpage>
            <pub-id pub-id-type="pmid">24778650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dumitrescu</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>McCune-Albright syndrome.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2008</year>
            <month>May</month>
            <day>19</day>
            <volume>3</volume>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">18489744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cornacchia</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bhushan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arguello</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A Case of Familial Male-Limited Precocious Puberty in a Child With Klinefelter Syndrome.</article-title>
            <source>J Endocr Soc</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>2</volume>
            <issue>10</issue>
            <fpage>1131</fpage>
            <page-range>1131-1136</page-range>
            <pub-id pub-id-type="pmid">30283825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplowitz</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of 104 children referred for evaluation of precocious puberty.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>89</volume>
            <issue>8</issue>
            <fpage>3644</fpage>
            <page-range>3644-50</page-range>
            <pub-id pub-id-type="pmid">15292280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mul</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fredriks</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>van Buuren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oostdijk</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Verloove-Vanhorick</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Wit</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Pubertal development in The Netherlands 1965-1997.</article-title>
            <source>Pediatr Res</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>50</volume>
            <issue>4</issue>
            <fpage>479</fpage>
            <page-range>479-86</page-range>
            <pub-id pub-id-type="pmid">11568291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biro</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Galvez</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Greenspan</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Succop</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Vangeepuram</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pinney</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Teitelbaum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Windham</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Kushi</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls.</article-title>
            <source>Pediatrics</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>126</volume>
            <issue>3</issue>
            <fpage>e583</fpage>
            <page-range>e583-90</page-range>
            <pub-id pub-id-type="pmid">20696727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borgstr&#x000f6;m</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fridstr&#x000f6;m</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gustafsson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ljungman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rodriguez-Wallberg</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>A prospective study on the long-term outcome of prepubertal and pubertal boys undergoing testicular biopsy for fertility preservation prior to hematologic stem cell transplantation.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>67</volume>
            <issue>9</issue>
            <fpage>e28507</fpage>
            <pub-id pub-id-type="pmid">32649054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Susman</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Houts</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Steinberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Belsky</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cauffman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dehart</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Roisman</surname>
                <given-names>GI</given-names>
              </name>
              <name>
                <surname>Halpern-Felsher</surname>
                <given-names>BL</given-names>
              </name>
              <collab>Eunice Kennedy Shriver NICHD Early Child Care Research Network</collab>
            </person-group>
            <article-title>Longitudinal development of secondary sexual characteristics in girls and boys between ages 91/2 and 151/2 years.</article-title>
            <source>Arch Pediatr Adolesc Med</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>164</volume>
            <issue>2</issue>
            <fpage>166</fpage>
            <page-range>166-73</page-range>
            <pub-id pub-id-type="pmid">20124146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biro</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Lucky</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Striegel-Moore</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pubertal correlates in black and white girls.</article-title>
            <source>J Pediatr</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>148</volume>
            <issue>2</issue>
            <fpage>234</fpage>
            <page-range>234-40</page-range>
            <pub-id pub-id-type="pmid">16492435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goyal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Khadgawat</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Precocious pseudopuberty due to virilising adrenocortical carcinoma progressing to central precocious puberty after surgery.</article-title>
            <source>BMJ Case Rep</source>
            <year>2019</year>
            <month>Mar</month>
            <day>12</day>
            <volume>12</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">30862670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lane</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Flowers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cheetham</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Adult height in patients with familial male-limited precocious puberty and the role of an aromatase inhibitor in patient management.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2018</year>
            <month>Apr</month>
            <day>25</day>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>551</fpage>
            <page-range>551-560</page-range>
            <pub-id pub-id-type="pmid">29654692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoseinpour</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ghanbari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Azad</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zare</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abdi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sajadi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Abbaszadeh</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Farahani</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Abdollahifar</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Ulmus minor bark hydro-alcoholic extract ameliorates histological parameters and testosterone level in an experimental model of PCOS rats.</article-title>
            <source>Endocr Regul</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>146</fpage>
            <page-range>146-153</page-range>
            <pub-id pub-id-type="pmid">31517633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Looijenga</surname>
                <given-names>LHJ</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Idrees</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Oct</month>
            <day>10</day>
            <volume>20</volume>
            <issue>20</issue>
            <pub-id pub-id-type="pmid">31658757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haddad</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Eugster</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>653</fpage>
            <page-range>653-61</page-range>
            <pub-id pub-id-type="pmid">17663289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armengaud</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Charkaluk</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Trivin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tardy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Br&#x000e9;art</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brauner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chalumeau</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>94</volume>
            <issue>8</issue>
            <fpage>2835</fpage>
            <page-range>2835-40</page-range>
            <pub-id pub-id-type="pmid">19454583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenfield</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Clinical review: Identifying children at risk for polycystic ovary syndrome.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>92</volume>
            <issue>3</issue>
            <fpage>787</fpage>
            <page-range>787-96</page-range>
            <pub-id pub-id-type="pmid">17179197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livadas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dracopoulou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dastamani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sertedaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maniati-Christidi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Magiakou</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Kanaka-Gantenbein</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Dacou-Voutetakis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>82</volume>
            <issue>4</issue>
            <fpage>543</fpage>
            <page-range>543-9</page-range>
            <pub-id pub-id-type="pmid">25041270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Creo</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Schwenk</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>Bone Age: A Handy Tool for Pediatric Providers.</article-title>
            <source>Pediatrics</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>140</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">29141916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Vries</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Horev</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Phillip</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>154</volume>
            <issue>6</issue>
            <fpage>891</fpage>
            <page-range>891-8</page-range>
            <pub-id pub-id-type="pmid">16728550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badouraki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Christoforidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Economou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dimitriadis</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Katzos</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of pelvic ultrasonography in the diagnosis and differentiation of various forms of sexual precocity in girls.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>819</fpage>
            <page-range>819-27</page-range>
            <pub-id pub-id-type="pmid">18951545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Root</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Precocious puberty.</article-title>
            <source>Pediatr Rev</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-9</page-range>
            <pub-id pub-id-type="pmid">10617758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papanikolaou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Michala</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Autonomous Ovarian Cysts in Prepubertal Girls. How Aggressive Should We Be? A Review of the Literature.</article-title>
            <source>J Pediatr Adolesc Gynecol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>292</fpage>
            <page-range>292-6</page-range>
            <pub-id pub-id-type="pmid">26228588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nunez</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Calis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Feuillan</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>88</volume>
            <issue>12</issue>
            <fpage>5730</fpage>
            <page-range>5730-3</page-range>
            <pub-id pub-id-type="pmid">14671160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mieszczak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Plourde</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Eugster</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>93</volume>
            <issue>7</issue>
            <fpage>2751</fpage>
            <page-range>2751-4</page-range>
            <pub-id pub-id-type="pmid">18397987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feuillan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Calis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shawker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Robey</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>92</volume>
            <issue>6</issue>
            <fpage>2100</fpage>
            <page-range>2100-6</page-range>
            <pub-id pub-id-type="pmid">17405850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eugster</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Reiter</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Plourde</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jou</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Pescovitz</surname>
                <given-names>OH</given-names>
              </name>
              <collab>McCune-Albright Study Group</collab>
            </person-group>
            <article-title>Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.</article-title>
            <source>J Pediatr</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>143</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <page-range>60-6</page-range>
            <pub-id pub-id-type="pmid">12915825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leschek</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Flor</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.</article-title>
            <source>J Pediatr</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>190</volume>
            <fpage>229</fpage>
            <page-range>229-235</page-range>
            <pub-id pub-id-type="pmid">29144249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplowitz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bloch</surname>
                <given-names>C</given-names>
              </name>
              <collab>Section on Endocrinology, American Academy of Pediatrics</collab>
            </person-group>
            <article-title>Evaluation and Referral of Children With Signs of Early Puberty.</article-title>
            <source>Pediatrics</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>137</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">26668298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Houk</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Kunselman</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls.</article-title>
            <source>Pediatrics</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>123</volume>
            <issue>6</issue>
            <fpage>e1059</fpage>
            <page-range>e1059-63</page-range>
            <pub-id pub-id-type="pmid">19482738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schumer</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Cannistra</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Granulosa cell tumor of the ovary.</article-title>
            <source>J Clin Oncol</source>
            <year>2003</year>
            <month>Mar</month>
            <day>15</day>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>1180</fpage>
            <page-range>1180-9</page-range>
            <pub-id pub-id-type="pmid">12637488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Featherstone</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fernando</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Theaker</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Simmonds</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mead</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease.</article-title>
            <source>J Urol</source>
            <year>2009</year>
            <month>May</month>
            <volume>181</volume>
            <issue>5</issue>
            <fpage>2090</fpage>
            <page-range>2090-6; discussion 2096</page-range>
            <pub-id pub-id-type="pmid">19286222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27607.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplowitz</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Oberfield</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society.</article-title>
            <source>Pediatrics</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>104</volume>
            <issue>4 Pt 1</issue>
            <fpage>936</fpage>
            <page-range>936-41</page-range>
            <pub-id pub-id-type="pmid">10506238</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
